|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/713 | |
| C12N 15/113 |
| (11) | Patento numeris | 3249052 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17162101.4 |
| Europos patento paraiškos padavimo data | 2007-05-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-11-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-04-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 799458 P | 2006-05-11 | US | |
| 817203 P | 2006-06-27 | US | |
| 840089 P | 2006-08-25 | US | |
| 829914 P | 2006-10-18 | US | |
| 901134 P | 2007-02-13 | US |
| (72) |
TAN, Pamela, US
BRAMLAGE, Birgit, US
FRANK-KAMENETSKY, Maria, US
FITZGERALD, Kevin, US
AKINC, Akin, US
KOTELIANSKI, Victor E., US
|
| (73) |
Alnylam Pharmaceuticals, Inc.,
300 Third Street, Cambridge, MA 02142,
US
|
| (54) | COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE PCSK9 GENE |
| COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE PCSK9 GENE |